Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Fumaric acid

Copy Product Info
😃Good
Catalog No. T3763Cas No. 110-17-8
Alias Trans-Butenedioic acid, Lichenic acid, Fumarate, Donitic acid, Allomaleic acid, 2-Butenedioic acid

Fumaric acid (2-Butenedioic acid) attenuates the eotaxin-1 expression in TNF-α-stimulated fibroblasts by suppressing p38 MAPK-dependent NF-κB signaling. Fumaric acid has recently been identified as an oncometabolite or an endogenous, cancer-causing metabolite. High levels of this organic acid can be found in tumors or biofluids surrounding tumors. Its oncogenic action appears due to its ability to inhibit prolyl hydroxylase-containing enzymes.

Fumaric acid

Fumaric acid

Copy Product Info
😃Good
Purity: 98.80%
Catalog No. T3763Alias Trans-Butenedioic acid, Lichenic acid, Fumarate, Donitic acid, Allomaleic acid, 2-Butenedioic acidCas No. 110-17-8
Fumaric acid (2-Butenedioic acid) attenuates the eotaxin-1 expression in TNF-α-stimulated fibroblasts by suppressing p38 MAPK-dependent NF-κB signaling. Fumaric acid has recently been identified as an oncometabolite or an endogenous, cancer-causing metabolite. High levels of this organic acid can be found in tumors or biofluids surrounding tumors. Its oncogenic action appears due to its ability to inhibit prolyl hydroxylase-containing enzymes.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
100 g$32-In Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.80%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Fumaric acid AI Summary
Fumaric acid is a multifaceted chemical that exhibits a broad range of bioactivities. In the context of Xenopus oocytes, it inhibits the Oat1-mediated [3H]PAH uptake with Ki values around 616,000 nM, while showing very weak inhibition of Oat6-mediated [3H]ES uptake with Ki values exceeding 31,622,776 nM. Additionally, it impacts 2-oxoglutarate-dependent human JMJD2E and human recombinant HIF PHD2, with IC50 values of 2,300,000 nM and 19,000 nM, respectively. In assays involving human recombinant PHD2 expressed in Escherichia coli, Fumaric acid exhibits an IC50 of 19,090 nM and demonstrates inhibition of the enzyme with a half-life of 6 hours. It is also a selective inhibitor of carbonic anhydrase isoforms, specifically showing more potent inhibition towards carbonic anhydrase 2 (Kinact of 10.5 μM) than isoform 1 (Kinact of 395 μM). Fumaric acid manifests other notable bioactivities, including agonism of the Thyroid Stimulating Hormone Receptor, and antagonism of the retinoid-related orphan receptor gamma. It induces DNA re-replication in SW480 colon adenocarcinoma cells and exhibits activity against HP1-beta Chromodomain interactions and ELG1-dependent DNA repair processes in HEK293T cells. Moreover, it shows moderate liver toxicity, confirmed by elevated serum activity levels of ALT or AST in 59% of clinical trial cases, without causing any acute liver toxicity or other severe liver conditions. Additionally, it inhibits urease activity in bacterial strains and human FBPase, and shows interaction with bacterial and human enzymes including FBPase and recombinant PHDs, with varying degrees of efficacy. Fumaric acid also demonstrates binding affinity towards several human receptors, exuding a manifold interaction profile across multiple biological pathways, indicating potential therapeutic applications contingent upon further detailed evaluations..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Fumaric acid (2-Butenedioic acid) attenuates the eotaxin-1 expression in TNF-α-stimulated fibroblasts by suppressing p38 MAPK-dependent NF-κB signaling. Fumaric acid has recently been identified as an oncometabolite or an endogenous, cancer-causing metabolite. High levels of this organic acid can be found in tumors or biofluids surrounding tumors. Its oncogenic action appears due to its ability to inhibit prolyl hydroxylase-containing enzymes.
SynonymsTrans-Butenedioic acid, Lichenic acid, Fumarate, Donitic acid, Allomaleic acid, 2-Butenedioic acid
Chemical Properties
Molecular Weight116.07
FormulaC4H4O4
Cas No.110-17-8
SmilesC(=C/C(O)=O)\C(O)=O
Relative Density.1.64. Temperature:20 °C.
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 62.5 mg/mL (538.47 mM), Sonication is recommended.
Chloroform, Dichloromethane, Ethyl Acetate, Acetone: Soluble
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM8.6155 mL43.0775 mL86.1549 mL430.7745 mL
5 mM1.7231 mL8.6155 mL17.2310 mL86.1549 mL
10 mM0.8615 mL4.3077 mL8.6155 mL43.0775 mL
20 mM0.4308 mL2.1539 mL4.3077 mL21.5387 mL
50 mM0.1723 mL0.8615 mL1.7231 mL8.6155 mL
100 mM0.0862 mL0.4308 mL0.8615 mL4.3077 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Fumaric acid | purchase Fumaric acid | Fumaric acid cost | order Fumaric acid | Fumaric acid chemical structure | Fumaric acid formula | Fumaric acid molecular weight